Characterization of KATP channels in intact mammalian skeletal muscle fibres
Open Access
- 1 March 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 123 (6) , 1103-1110
- https://doi.org/10.1038/sj.bjp.0701727
Abstract
The aim of this study was to characterize the KATP channel of intact rat skeletal muscle (rat flexor digitorum brevis muscle). Changes in membrane currents were recorded with two‐electrode voltage‐clamp of whole fibres. The KATP channel openers, levcromakalim and pinacidil (10–400 μM), caused a concentration‐dependent increase in whole‐cell chord conductance (up to approximately 1.5 mScm−2). The activated current had a weak inwardly rectifying current‐voltage relation, a reversal potential near EK and nanomolar sensitivity to glibenclamide – characteristic of a KATP channel current. Concentration‐effect analysis revealed that levcromakalim and pinacidil were not particularly potent (EC50 ∼186 μM, ∼30 μM, respectively), but diazoxide was completely inactive. The ability of both classical KATP channel inhibitors (glibenclamide, tolbutamide, glipizide and 5‐hydroxydecanoic acid) and a number of structurally related glibenclamide analogues to antagonize the levcromakalim‐induced current was determined. Glibenclamide was the most potent compound with an IC50 of approximately 5 nM. However, the non‐sulphonylurea (but cardioactive) compound 5‐hydroxydecanoic acid was inactive in this preparation. Regression analysis showed that the glibenclamide analogues used have a similar rank order of potency to that observed previously in vascular smooth muscle and cerebral tissue. However, two compounds (glipizide and DK13) were found to have unexpectedly low potency in skeletal muscle. These experiments revealed KATP channels of skeletal muscle to be at least 10× more sensitive to glibenclamide than previously found; this may be because of the requirement for an intact intracellular environment for the full effect of sulphonylureas to be realised. Pharmacologically, KATP channels of mammalian skeletal muscle appear to resemble most closely KATP channels of cardiac myocytes. British Journal of Pharmacology (1998) 123, 1103–1110; doi:10.1038/sj.bjp.0701727Keywords
This publication has 35 references indexed in Scilit:
- Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptorNature, 1997
- Pharmacological characterization of the sulphonylurea receptor in rat isolated aortaBritish Journal of Pharmacology, 1997
- A Family of Sulfonylurea Receptors Determines the Pharmacological Properties of ATP-Sensitive K+ ChannelsPublished by Elsevier ,1996
- Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea ReceptorScience, 1995
- EVIDENCE THAT IMIDAZOL(ID)INE‐ AND SULPHONYLUREA‐BASED ANTAGONISTS OF CROMAKALIM ACT AT DIFFERENT SITES IN THE RAT THORACIC AORTAClinical and Experimental Pharmacology and Physiology, 1993
- Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscleBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitroJournal of Autonomic Pharmacology, 1989
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K+ channel in insulin secreting cellsBiochemical and Biophysical Research Communications, 1987
- Muscular fatigue investigated by phosphorus nuclear magnetic resonanceNature, 1978